Migraine Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 65 years.
- People of Caucasian ethnicity.
- People who have been diagnosed by a headache specialist neurologist with either high-frequency episodic migraine (more than 8 migraine days per month) or chronic migraine, based on recognised international headache diagnostic guidelines.
- People who have had a history of migraine for at least one year.
- People whose preventive migraine treatment has remained unchanged in the month before starting the study, and who have not received botulinum toxin injections in that same month.
- People who are able to clearly describe their symptoms and headache characteristics.
- People who are willing to provide written informed consent to participate.
Who may not be able to join:
- People who have another type of headache that is not migraine, except for headaches caused by overuse of pain relief medication.
- People who show signs of a neurological problem on examination (confirm with trial site).
- People who are pregnant or breastfeeding.
- People who have a cognitive impairment or other condition that could prevent them from completing the study properly.
- People who need to change their preventive migraine treatment within the first 6 months after starting the study medication.
- People who experience a serious side effect that requires the study medication to be stopped or changed.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ana Beatriz Gago Veiga, Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Phone: +34 915202416
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Biomarkers of positive initial response to monoclonal antibodies
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.